UNderstanding uptake of Immunisations in TravellIng aNd Gypsy communities (UNITING): protocol for an exploratory, qualitative study by Jackson, Cath et al.
UNderstanding uptake of
Immunisations in TravellIng aNd Gypsy
communities (UNITING): protocol for
an exploratory, qualitative study
Cath Jackson,1 Helen Bedford,2 Louise Condon,3 Annie Crocker,4 Carol Emslie,5
Lisa Dyson,1 Bridget Gallagher,6 Susan Kerr,5 Helen J Lewis,1 Julie Mytton,7
Sarah A Redsell,8 Frieda Schicker,9 Christine Shepherd,10 Lesley Smith,10
Linda Vousden,11 Francine M Cheater12
To cite: Jackson C,
Bedford H, Condon L, et al.
UNderstanding uptake of
Immunisations in TravellIng
aNd Gypsy communities
(UNITING): protocol for an
exploratory, qualitative study.
BMJ Open 2015;5:e008564.
doi:10.1136/bmjopen-2015-
008564
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-008564).
Received 21 April 2015
Accepted 22 May 2015
For numbered affiliations see
end of article.
Correspondence to
Dr Helen Bedford;
h.bedford@ucl.ac.uk
ABSTRACT
Introduction: Gypsies, Travellers and Roma (referred to
here as Travellers) experience significantly poorer health
and have shorter life expectancy than the general
population. They are also less likely to access health
services including immunisation. To improve
immunisation rates, we need to understand what helps
and hinders individuals in these communities in taking
up immunisations. This study has two aims: (1)
Investigate the barriers and facilitators to acceptability
and uptake of immunisations among six Traveller
communities in the UK; (2) Identify potential
interventions to increase uptake in these Traveller
communities.
Methods and analysis: A three-phase qualitative study
with six Traveller communities. PHASE 1: In each
community, we will explore up to 45 Travellers’ views
about the influences on their immunisation behaviours
and ideas for improving uptake in their community.
PHASE 2: In each community, we will investigate 6–8
service providers’ perspectives on barriers and facilitators
to childhood and adult immunisations for Traveller
communities with whom they work, and ideas to improve
uptake. Interview data will be analysed using the
Framework approach. PHASE 3: The findings will be
discussed and interventions prioritised in six workshops,
each with 10–12 phase 1 and 3–4 phase 2 participants.
Ethics and dissemination: This research received
approval from NRES Committee Yorkshire and The
Humber-Leeds East (Ref. 13/YH/02). It will produce (1)
findings on the barriers and facilitators to uptake of
immunisations in six Traveller communities; (2) a
prioritised list of potentially feasible and acceptable
interventions for increasing uptake in these communities;
and (3) methodological development in undertaking
research with diverse Traveller communities. The study
has the potential to inform new ways of delivering
services to ensure high immunisation uptake. Findings
will be disseminated to participants, relevant UK
organisations with responsibility for the implementation
of immunisation policy and Traveller health/welfare; and
submitted for publication in academic journals.
Trial registration number: ISRCTN20019630.
INTRODUCTION
Travellers typically experience signiﬁcantly
poorer health and shorter life expectancy com-
pared to the general population.1–6 (Note.
Throughout this paper, we use the term
Traveller in its broadest sense to include dis-
tinct and diverse Gypsy, Traveller and Roma
communities, who may be settled or nomadic,
and may live on authorised or unauthorised
sites or in houses). Despite a greater health
need, there is low uptake of health services by
Travellers, including preventive healthcare.1–6
Barriers to uptake stem partly from a lack of
consideration of Traveller culture by health
providers when developing services, for
example, a reluctance by general practitioner’s
(GP) practices to register transient Travellers.7
Further barriers are a history of discrimination
leading to mistrust of people and institutions,
poverty, low health literacy and, in some com-
munities, strong beliefs of ‘stoicism’, ‘self-
reliance’ and ‘fatalism’ about health.7
Strengths and limitations of this study
▪ This is the first large-scale multi-community
qualitative study exploring barriers and facilita-
tors to childhood and adult immunisation for
Travellers in the UK.
▪ The findings will have the potential to inform new
ways of delivering accessible immunisation services
to socially excluded, marginalised communities.
▪ Our research team may be perceived as ‘outsi-
ders’, resulting in difficulties in engaging with
Travellers to participate.
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The public health beneﬁts and cost-effectiveness of
immunisation are well established.8 In the UK, the
uptake rates for scheduled immunisations in children
up to 6 years are generally high and stable, approaching
or meeting the 95% target required for herd immun-
ity.9 10 Until the 2011 census,11 ethnic group classiﬁca-
tions did not provide for Travellers to ‘self-identify’.
Moreover, ethnic group is not routinely collected during
registration with aGP, and even now may be incomplete
or poorly coded.12 There is, therefore, a lack of accurate
information about the take-up of immunisations in
Traveller communities. That said, local studies using
parent self-report13–16 and National Health Service
(NHS) records14 17 suggest low or variable uptake of
childhood immunisation. These patterns mirror data for
other disadvantaged groups which are more likely to be
unimmunised or not up to date, signiﬁcantly increasing
their risk (and consequent spread) of vaccine prevent-
able disease.18 19
A large body of literature20–24 identiﬁes two broad cat-
egories of parental factors inﬂuencing uptake of child-
hood immunisation in the general population and
high-risk groups.25 The ﬁrst relates to socioeconomic dis-
advantage where, despite being motivated to have their
children vaccinated, parents lack access to resources and
support to overcome logistical barriers such as having no
private transport. The second relates to parents’ concerns
about the safety or beliefs about the necessity of vaccines.
There are differences in parents who accept immunisa-
tion but do not complete the course (partial immuni-
sers), those who have concerns about the safety of some
vaccines but not others (selective immunisers) and those
who reject immunisation altogether (non-immunisers).26
These different groups are likely to require different
interventions. Regardless of parental position on immun-
isation, trust in health professionals and services is
paramount. Studies have also explored factors inﬂuen-
cing uptake of immunisation in adults27 28 including
those with ‘high risk’ conditions29 and minority ethnic
groups.30 The barriers appear to fall into the same two
categories, access and beliefs, including the perception
that healthy people do not need immunisations.27
Many of the issues identiﬁed in this literature are
likely to be similar for Travellers. However to develop
interventions that are tailored to the needs of diverse
Traveller communities, further research with these
communities is required. To date, a small number of
studies13–17 have explored the barriers to immunisation
uptake speciﬁcally in Traveller communities. These iden-
tify multiple issues reﬂecting the difﬁculties experienced
by marginalised, socially excluded communities.1–6
However, these studies tend to be small and focused on
one community. While Traveller communities may share
similar features of lifestyle that distinguish them from
the general population, they have different beliefs and
cultural traditions.31 It is therefore important to under-
stand whether and how speciﬁc communities differ in
the factors that promote or inhibit immunisation.
Second, immunisation is often only one small part of a
study exploring several health issues with Travellers. This
limits the extent to which the complex nature of barriers
and facilitators to immunisation is explored. For
example, barriers may be speciﬁc to particular vaccines,
for example, measles, mumps rubella (MMR) vaccine,
or differ for adult and childhood vaccines. Third, most
studies were conducted in the 1980s/1990s, so do not
consider issues associated with the introduction of new
vaccines in the UK childhood immunisation schedule
(eg, Rotavirus in July 201332), evolving views about previ-
ously controversial vaccines (eg, pertussis, MMR) or the
views of more recent migrant communities in the UK,
for example, Romanian Roma. Finally, we have found no
studies on immunisation uptake in adults living in
Traveller communities.
The effectiveness of interventions to increase immun-
isation uptake among children33 and adults34 35 has also
been reviewed and there are many examples of innova-
tive health and social care provision aimed at improving
the health of Travellers.1 2 36 Some target immunisation
speciﬁcally (eg, outreach immunisation programmes, tai-
lored health promotion resources), whereas others are
generic yet relevant to immunisation (hand-held patient
records, specialist health visitors1 and cultural compe-
tence training of health professionals37). These interven-
tions are rarely rigorously evaluated, so it is unclear
which are feasible, acceptable and (cost) effective, in
which communities they work and how they may (not)
work. Finally, existing interventions are rarely informed
by theoretical frameworks which can increase effective-
ness by aiding understanding of the likely mechanisms
of change.38 Our research will advance understanding
by addressing the limitations of previous research. The
aims and objectives are as follows.
Aims
1. Investigate the barriers and facilitators to acceptabil-
ity and uptake of immunisations among six Traveller
communities (comprising ﬁve distinct ethnic/cultural
groups) across four UK cities;
2. Identify possible interventions to increase uptake of
immunisations in these Traveller communities, which
could be tested in a subsequent feasibility study.
Objectives
1. Investigate the views of Travellers on the barriers and
facilitators to acceptability and uptake of immunisa-
tions and explore their ideas for improving immun-
isation uptake;
2. Examine whether and how these responses vary
across and within communities, and for different vac-
cines (childhood and adult);
3. Investigate the views of service providers on the bar-
riers and facilitators to uptake of immunisations
within the Traveller communities with whom they
work, and explore their ideas for improving immun-
isation uptake;
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4. Examine whether and how these responses vary
within and across communities, for different vaccines
(childhood and adult) and for different service pro-
vider roles;
5. Use the data collected from (1 to 4) to identify pos-
sible interventions to increase uptake of immunisa-
tions in the six Traveller communities;
6. Conduct Feedback Workshops in each community to
discuss ﬁndings and to produce a prioritised list of
potentially feasible and acceptable interventions to
be considered for testing in a subsequent feasibility
study.
METHODS AND ANALYSIS
Study design
This three-phase qualitative study is the ﬁrst ‘intervention
development’ stage of the Medical Research Council
Framework for developing and evaluating complex inter-
ventions.38 Phase 1 comprises qualitative semistructured,
group and individual interviews in six Traveller communi-
ties. Phase 2 comprises qualitative semistructured individ-
ual interviews with service providers. In phase 3,
Feedback Workshops will be held with each Traveller
community and associated service providers to produce a
prioritised list of potentially feasible and acceptable inter-
ventions for future development and testing. The theor-
etical framework underpinning the study is the Social
Ecological Model (SEM, ref. 39) which recognises that
individuals’ behaviour is affected by, and conversely
impacts on, multiple levels of inﬂuence (intrapersonal,
interpersonal, institutional, community and policy). The
SEM has previously been used in the context of ﬂu
immunisation,40 child health41 and with culturally
diverse42 and disadvantaged populations.43
Setting and participants
Setting
The study will focus on six Traveller communities and be
undertaken in four UK cities (York, Bristol, Glasgow and
London (see table 1). Five of the communities (English
Roma, English Gypsies, European Roma, Irish Traveller)
were originally recognised in the Race Relations
Act 1976 as ethnic minorities,44 replaced now by the
2010 Equality Act.45 While they have different beliefs,
customs and languages, they share common features of
lifestyle and culture44 and are genealogically and linguis-
tically related.46 In contrast, Showpeople are not recog-
nised in these Acts or perceived by the aforementioned
communities as being part of the ‘traditional Travellers’
ethnic group. We include Eastern European Roma
communities in Bristol and Glasgow because this is the
newest and most under-researched Traveller community
in the UK. In addition, these are communities that
have travelled from different countries (Slovakia or
Romania), speak different languages (Slovakian Roma
or Romanian Roma) and therefore cannot be assumed
to be similar.
Participants
Phase 1: In each Traveller community, we will recruit men
and women living in extended families across genera-
tions. We will include young women planning families,
parents and grandparents to capture a lifespan/cross-
generational perspective. We will actively seek partici-
pants eligible for speciﬁc vaccines including teenage girls
for views on their 3-in-1 teenage booster (diphtheria,
tetanus, poliomyelitis; given at around 14 years of age)
and human papilloma virus (HPV) vaccine (given at 12–
13 years); and adults who are pregnant, over 65 years or
have long-term conditions for views on ﬂu and pertussis
vaccines). Typically, decisions on childhood immunisa-
tion are made by mothers;20 21 however, we are keen to
recruit men and women to explore any potential gender
differences in views; we will therefore aim for a quarter of
participants to be male. We will purposively seek to
recruit a mix of full immunisers/partial/selective immu-
nisers and non-immunisers (based on self-report26). We
aim to interview approximately 24 to 45 participants in
each of the six Traveller communities (total 144–270 par-
ticipants). This large sample size will enable us to look
for potential differences and similarities in views about
both childhood and adult vaccines within a community
across gender and age as well as draw out meaningful
comparisons across Traveller communities, to allow robust
conclusions to be made.
Phase 2: Service providers in the four cities will be
recruited to the study. We will purposively sample to
ensure that we interview a mix of ‘frontline workers’ (eg,
health visitors, practice nurses, community midwives,
school nurses, GPs, range of community workers includ-
ing the third sector) and those working in more stra-
tegic/commissioning roles (eg, local decision-makers in
health protection/public health/Health and Wellbeing
Boards/Clinical Commissioning Groups). We will aim to
interview six to eight service providers in each city (total
24 to 32 participants). Examples of organisations and
providers that we intend to approach are presented in
table 1. These organisations were identiﬁed prior to the
NHS reforms in April 2013.
Phase 3: A subsample of participants from phases 1
and 2 will be invited to take part in the ‘Feedback
Workshops’, speciﬁcally between 10 and 12 Traveller par-
ticipants per community and three to four service provi-
ders (13 to 16 participants in total per workshop; six
workshops comprising 78 to 96 participants). Ideally, we
will attract a mix of Traveller men and women, across
ages (including teenage girls) with different experiences
of immunisations; and a mix of frontline service provi-
ders and those with a more strategic role.
Access and recruitment
This is a complex, multisite project working with socially
excluded, marginalised communities who are tradition-
ally hard to engage in research.47
Phase 1: In each community, we will use a multi-
pronged approach to access and recruitment. We are
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aware that our position of researchers as ‘outsiders’ with
few similarities of experience and no ‘network connec-
tions’ with participant Traveller communities could
result in difﬁculties in gaining access.47 Our research
team includes ‘comprehensive gatekeepers’47 who have
long-standing relationships with the communities and
who can ‘vouch’ for our trustworthiness and thereby
enable access and help recruit participants to the study.
The proposed approach is based on the experience of
these gatekeepers as well as drawing on established good
practice.48 We will attend existing groups where
members of the community routinely meet together. We
will also promote the study via the local ‘frontline
workers’ and, where appropriate, accompany them on
visits to Traveller sites. We will meet with ﬁve or six
members of each community throughout the study to
inform the research process including recruitment.
These ‘Community Partners’ will help ensure that issues
such as access, recruitment and dissemination methods
are acceptable. ‘Community Partners’ will be offered a
£40 gift voucher of their choice per meeting in line with
recommended payment for University public involve-
ment groups.49
The study will be discussed with members of the com-
munity and written information provided for people to
read or have read to them by others to aid discussions
with family members and peers. For the two European
Roma communities, information will be in English and
Romanian/Slovakian. We will return a week later to
establish who might wish to take part, and to arrange a
time and place for the interview. We will regularly meet
with the community during the recruitment phase.
Table 1 Overview of participating Traveller communities and examples of service providers linked to these communities
(at the start of the study)
City Community Overview46
York English Roma Recognised in British Law as an ethnic group. 350+ families living across three official sites
(54 pitches) and some in housing.
Examples of organisations/workers: City of York Council-Lead for Traveller and Ethnic
Minority Services, Traveller Support Worker; Joseph Rowntree Foundation, NHS York
(moving to City of York Council in 2013)—Lead for Traveller Health, Health professionals
based at GP practices close to the three official sites, Health visitor who worked at Personal
Medical Service for Homeless People and Travellers Families project in York. This Service
closed in 2011
Bristol Eastern European
Roma
Descended from the same people as British Romany Gypsies and have recently moved to
the UK from Central and Eastern Europe. Recognised as the same ethnic category as
British Gypsies yet distinct from the UK community. 40 families in shared rented
accommodation in relative proximity to each other.
Examples of organisations/workers: Bristol, North Somerset and South Gloucestershire
Strategic Group for Traveller Health, Immunisation leaders in Bristol NHS, local Health
Protection Unit, Bristol City Council Gypsy and Traveller team, designated Health Visitor,
Roma worker funded by the church where the drop-in is located
English Gypsy Recognised in British Law as an ethnic group. 100+ families living on two council managed
Traveller sites.
Examples of organisations/workers: As for Eastern European Roma
Glasgow Eastern European
Roma
See Eastern European Roma in Bristol for overview. Based on GP records, there are 1800
residents housed in a very small geographical area in Govanhill (8 streets).
Examples of organisations/workers: One full-time health visitor and two support workers
(one bilingual) who are employed to work solely with the Roma Community in Govanhill,
health professionals at Govanhill Health Centre, Oxfam, Govanhill Housing Association,
Daisy Street Neighbourhood Centre, Govanhill Law Centre, Glasgow Community Health
Partnership
Scottish Show
People
Scottish showman or travelling show, circus and fairground families. Not recognised in
British Law as an ethnic group. Approximately 300 live in fixed sites in the North East of
Glasgow. Some sites are owned by the council and some are privately owned. Examples of
organisations/workers: Glasgow Community Health Partnership, health professionals at
local Health Centre
London Irish Traveller Traditionally nomadic people of Celtic descent who arrived in Britain in the 1850s.
Recognised in British Law as an ethnic group.17 000 live in London. Most live in rented
accommodation and on local authority sites. The London Gypsy and Traveller Unit works
with approximately 800 families.
Examples of organisations/workers: London Gypsy Traveller Forum, Greater London
Authority Public Health Team, Irish Traveller Movement, Southwark Travellers Action Group
These organisations were identified prior to the NHS reforms in April 2013.
GP, general practitioner; NHS, National Health Service.
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Phase 2: In each city, we will establish a list of contacts
of the relevant service providers. We will approach these
people by email, in the ﬁrst instance, with a participant
information sheet (PIS) and then follow this up with a
telephone call a week later. Our existing links to the
multiple agencies working in each city will also be used
to facilitate introductions.
Phase 3: Participants in phases 1 and 2 who agree to
be contacted about phase 3 will be reapproached using
their preferred method of contact and provided with a
PIS about the Feedback Workshop. Where insufﬁcient
phase 1 participants are able to attend, we will seek to
recruit new members of the community to attend the
workshop.
Data collection
Phase 1: We will conduct small group interviews with
members of the same family to elicit a cross-generational/
lifespan perspective. We also plan to run group interviews
with teenage girls, and with young women planning fam-
ilies, pregnant women and those with preschool children,
to capture peer inﬂuence on immunisation decisions.
While immunisation may not seem a particularly sensitive
issue (with the exception of HPV), group interviews may
not be appropriate or favoured. We will, therefore be ﬂex-
ible about whom and how many participants take part in
an interview. Individual and group interviews will be con-
ducted face to face in participants’ choice of setting. With
the consent of participants, interviews will be recorded
digitally and transcribed verbatim. Interpreters will be
employed for Roma interviews.
Phase 2: We will conduct individual interviews with the
service providers face to face in participants’ choice of
setting. With their consent, interviews will be recorded
digitally and transcribed verbatim.
In phases 1 and 2, we will use topic guides for the
interviews to ensure consistency; however, the format will
be ﬂexible to allow participants to generate naturalistic
data on topics they view as important. We will explicitly
pursue negative cases (‘elements in the data that appear
to contradict the emerging view’) (ref. 50, p. 51) to
enhance the validity of our developing propositions.
Topics will be revised as necessary on the basis of emer-
ging evidence from preceding interviews. The SEM39
will inform the questions that we ask, ensuring that we
explore all ﬁve levels of inﬂuence on immunisation
behaviour. Research team members’ local knowledge of
immunisation and the Traveller community will also
feed into the development of topic guides to prompt dis-
cussion of particular local issues (eg, outbreaks of
measles, introduction/removal of specialist services).
Topic guides will be reviewed and piloted with the
‘Community Partners’.
At the end of phases 1 and 2, for each of the six
Traveller communities, we will (1) understand the poten-
tial barriers and facilitators for take-up of immunisations
(across all ﬁve levels of the SEM) and (2) have ideas for
the content and delivery of potentially feasible and
acceptable interventions to increase immunisation
uptake for all ﬁve levels of the SEM. We will have insight
into whether the barriers and facilitators and interven-
tions are similar or different dependent on the gender,
age and self-reported immunisation history of Traveller
participants, the professional role of service providers
and across different vaccines (childhood/adult). These
outputs will be presented at the Feedback Workshops in
Phase 3.
Phase 3: A Feedback Workshop will be held locally for
each Traveller community. The aim of the workshops is
to disseminate the ﬁndings of phases 1 and 2 and to
discuss and ‘co-produce’47 ideas for the content and
delivery of potentially feasible and acceptable interven-
tions at all ﬁve levels of the SEM. Following the presenta-
tion of the ﬁndings, we will use a structured two-step
process.51 First, participants will independently rate sug-
gested interventions for potential impact. Using these
ratings, Travellers and service providers will then work
together to jointly agree on a prioritised list of poten-
tially feasible and acceptable interventions which could
positively impact on immunisation uptake in their
community.
Data analysis
Within-community
Phases 1 and 2: Interviews will be fully transcribed and
data subjected to thematic analysis using the Framework
approach,52 which is designed to address applied policy-
related questions.52 The Framework approach has previ-
ously been used in a large UK qualitative study exploring
health issues with Gypsies and Travellers.53
The ﬁve stages of analysis, speciﬁed below, will ﬁrst be
undertaken independently for each of the six Traveller
communities and for both phase 1 and phase 2 data.
This ‘within-community’ analysis will be led by CJ, LD
and CE. Members of the research team based in each
city will contribute at stages 2 and 5. This will enhance
rigour and ensure that the local context in which the
data are collected and where participants live is appro-
priately considered. NVivo software will facilitate data
management.
1. Familiarisation—The interview transcripts will be read
and emerging ideas and recurrent themes recorded.
2. Identifying a thematic framework—A thematic framework
will be set up in which the interview data will be orga-
nised. This will be informed by the SEM. Additional
themes representing emerging issues from the data
will be added. The framework will be applied to
three to four transcripts to reﬁne. The same thematic
framework will be used to analyse the data for all the
six Traveller communities and associated service
providers.
3. Indexing—The thematic framework will be systematic-
ally applied to the interview data.
4. Charting—Charts will be drawn up for each theme
and summaries of responses from participants (and
verbatim quotes) entered. This will enable us to
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consider the range of views within each theme, that
is, on (1) barriers, (2) facilitators to immunisation,
(3) ideas for intervention across the ﬁve levels of the
SEM; and (4) other emerging issues.
5. Mapping and interpretation—The charts will be
reviewed and interrogated to compare and contrast
views, as well as to seek patterns, connections and
explanations within the data.
Cross-community synthesis
The ﬁnal outputs of the analysis of phase 1 and 2 data
will be a thematic synthesis that takes account of the
inferences derived from all the interview data for the
sample as a whole.54 Using the charts created in stage 4
of the analysis for each community (both Travellers and
service providers), we will synthesise the data across all
six communities to explore similarities and differences
in views on the same four areas: (1) barriers; (2) facilita-
tors to immunisation; (3) ideas for intervention across
the ﬁve levels of the SEM; and (4) other emerging
issues. At this stage, we will also look for similarities and
differences in views of the two European Roma commu-
nities living in different cities. Our earlier analysis
exploring ‘within-community’ (eg, gender) patterns of
responses will be extended across communities to
enable us to identify the transferability of these features
across communities.
ETHICS AND DISSEMINATION
Ethics
This research has received approval from NRES
Committee Yorkshire and The Humber—Leeds East
(Ref. 13/YH/02). Drawing on the British Psychological
Society’s Code of Human Research Ethics,55 there are
three key ethical issues. First (principle of social responsi-
bility55), it is a qualitative study with the primary output
being a list of prioritised interventions to increase uptake
for testing in a subsequent research study, rather than
making actual changes to services. There is, therefore, a
risk that we will raise unrealistic expectations of what this
research can achieve in the short term with a lack of tan-
gible beneﬁts to the Traveller communities themselves,
particularly those members who are transient. We will be
very clear from the outset about the purpose of the
research and work with our ‘Community Partners’
throughout the study to ensure that this stated purpose is
widely disseminated. All Traveller participants will be
offered a £15 voucher of their choice towards any costs
of participation and in recognition of their time
following the interview (£25 for attending the Feedback
Workshop). Second (principle of valid consent55), it is
likely that there will be low literacy and people for whom
English is their second or even third language within the
participating Traveller communities.1 2 5 The PIS for each
community will be developed with our ‘Community
Partners’ using simple language and images; and trans-
lated for Roma communities. Third (principle of valid
consent55), according to Gillick competence,56 the
teenage girls (under 16 years of age) could consent for
themselves to take part in an interview about immunisa-
tion if they have sufﬁcient understanding and intelli-
gence to understand fully what is proposed. However, we
are mindful that Traveller communities commonly
remove their children from sex education classes in
school,57 and so may be unwilling for their daughters to
participate in a discussion about an immunisation to
protect against infections transmitted through sexual
behaviour (HPV vaccine). We will therefore seek assent
from the girls themselves and consent from a parent.
Outputs and dissemination
There will be three key outputs:
1. Comprehensive, in-depth ﬁndings on the barriers
and facilitators to uptake and acceptability of child-
hood/adult immunisation both within and across six
Traveller communities living in four cities across
England and Scotland.
2. A prioritised list of potentially feasible and acceptable
interventions for increasing immunisation uptake
across the ﬁve levels of the SEM for these Traveller
communities.
3. Methodological development in undertaking research
with diverse Traveller communities living in different
localities. Historically, research has been small scale,
localised and with one community. Lessons learnt
from this large-scale multi-city qualitative study can be
used to improve the quality of future research in
Traveller communities of a similar scale.
The ﬁndings will be published within the ﬁnal report to
the National Institute for Health Research
Health Technology Assessment (NIHR HTA) programme.
A local summary will be disseminated to the community
and local organisations with whom we have worked to
access/recruit Traveller participants to the study and to
service providers in that locality who took part. A summary
of the ﬁndings on the barriers and facilitators to uptake
and acceptability of immunisation for all six Traveller com-
munities will be sent to relevant national UK agencies and
organisations responsible for the implementation of
immunisation policy and Traveller health and welfare
including professional bodies. We will also submit research
papers to relevant professional journals and conferences.
Academic papers will be submitted for publication in high-
impact peer-reviewed journals.
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